James Roy Knowles, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4235 Indian Ripple Rd, Ste 100, Beavercreek, OH 45440 Phone: 937-427-2020 Fax: 937-429-1144 |
Mary Ellen Weimer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 89 Sylvania Dr Fl 1, Beavercreek, OH 45440 Phone: 937-320-2020 |
Dr. Sung Kwong Or, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1538 Marsetta Dr, Beavercreek, OH 45432 Phone: 937-427-2828 Fax: 937-427-2880 |
Martin F Wilkes, MD Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 89 Sylvania Dr Fl 2, Beavercreek, OH 45440 Phone: 937-427-8900 Fax: 937-427-1710 |
Dr. Jennifer Marie Shade, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 89 Sylvania Dr, Beavercreek, OH 45440 Phone: 937-320-2020 |
Scott Davies Schoenberger, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 89 Sylvania Dr, Floor 2, Beavercreek, OH 45440 Phone: 937-427-8900 |
Dr. Leah K. Cloud, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 89 Sylvania Dr, Beavercreek, OH 45440 Phone: 937-320-2020 Fax: 937-320-0504 |
Dr. Brian Ray Stahl, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4235 Indian Ripple Rd, Ste 100, Beavercreek, OH 45440 Phone: 937-427-2020 Fax: 937-429-1144 |
News Archive
Approval is expected to be granted in the United States for a new drug to treat HIV infections.
Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer ("tonsil cancer") harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. For some patients, this may mean successful treatment with radiation alone and avoiding the side effects of chemotherapy.
Today, Novo Nordisk announced that Judge Avern Cohn of the US District Court for the Eastern District of Michigan issued an adverse ruling in a patent litigation case regarding Novo Nordisk's US Patent No. 6,677,358. The district court ruled that the patent, which covers the combination use of repaglinide and metformin for the treatment of type 2 diabetes, is invalid and unenforceable.
In a remarkably rapid translation of laboratory research findings into a treatment with the potential to benefit patients, UC San Francisco scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic multiple sclerosis (MS).
› Verified 6 days ago